EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of the in vitro quality parameters of cold‐stored platelets containing aggregates

Lacey Johnson iD, Christopher Roan, Pearl Lei, Denese C Marks iD

Vox Sanguinis · 2025

DOI: 10.1111/vox.70064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Lacey Johnson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia. Hauptthemen laut MEDLINE: Blood Platelets, Blood Preservation, Platelet Aggregation, Cryopreservation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Governments.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Cold‐stored platelets (CSP) are being used more widely for the treatment of bleeding because of their longer shelf life. However, storage at low temperatures can induce the formation of platelet aggregates. We aimed to study the impact of aggregate formation on platelet quality and function. Materials and Methods Apheresis platelets (40% plasma/60% platelet additive solution [PAS‐E]) were refrigerated (2–6°C) for 21 days. CSP that developed aggregates ( n = 44) were compared with CSP with no aggregates (controls; n = 45). A subset of aggregated CSP ( n = 15) was tested before and after being passed through a transfusion administration set containing a 200‐μm filter. Donor‐ and collection‐related parameters and in vitro quality parameters were assessed.

Results

Aggregates were identified in 10.9% of CSP, primarily being found following extended storage (median: 16 days). The platelet count was not different between the aggregated (928 ± 158 × 10 9 /L) and control (931 ± 136 × 10 9 /L; p = 0.920) components at day 21. The pH of aggregated components was lower, and the platelets in aggregated components displayed a greater loss of GPIbα, externalization of CD62P and annexin‐V, release of extracellular vesicles and degranulation, compared to controls. Functionally, aggregated CSP had potentiated aggregation responses but reduced clot strength (thromboelastography maximum amplitude [TEG MA]) compared to controls. Filtration reduced aggregates in CSP but retained the platelet count and functional properties. Donor‐related factors did not correlate with aggregate formation, although certain collection parameters may be implicated.

Conclusion

Platelets within components that contained aggregates were more activated than non‐aggregated controls. The propensity for aggregate formation should be considered when selecting a shelf life for CSP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsBlood PreservationPlatelet AggregationCryopreservationHumansCold TemperatureMaleFemale

Stichwörter der Autor:innen

aggregatesapheresiscold‐storedplateletplatelet additive solutionrefrigeration

Autor:innen und Institutionen

  • Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.
  • Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Lacey Johnson, Denese C Marks

Förderung

  • Australian Governments

Zitieren

APA

Johnson, L., Roan, C., Lei, P., & Marks, D. C. (2025). Characterization of the in vitro quality parameters of cold‐stored platelets containing aggregates. Vox Sanguinis. https://doi.org/10.1111/vox.70064

Vancouver

Johnson L, Roan C, Lei P, Marks DC. Characterization of the in vitro quality parameters of cold‐stored platelets containing aggregates. Vox Sanguinis. 2025. doi:10.1111/vox.70064

BibTeX
@article{Johnson2025,
  author = {Johnson, Lacey and Roan, Christopher and Lei, Pearl and Marks, Denese C},
  title = {Characterization of the in vitro quality parameters of cold‐stored platelets containing aggregates},
  journal = {Vox Sanguinis},
  year = {2025},
  doi = {10.1111/vox.70064}
}
Kostenlos starten →